Altrius Capital Management Inc Invests $297,000 in Axon Enterprise, Inc. (NASDAQ:AXON)

Altrius Capital Management Inc acquired a new stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 500 shares of the biotechnology company's stock, valued at approximately $297,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of AXON. Asset Dedication LLC boosted its stake in shares of Axon Enterprise by 11.3% in the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company's stock valued at $106,000 after purchasing an additional 18 shares in the last quarter. Bleakley Financial Group LLC lifted its stake in Axon Enterprise by 1.3% in the 4th quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company's stock valued at $908,000 after purchasing an additional 20 shares during the last quarter. Venturi Wealth Management LLC boosted its position in Axon Enterprise by 2.7% in the fourth quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company's stock valued at $477,000 after buying an additional 21 shares in the last quarter. Insigneo Advisory Services LLC grew its stake in shares of Axon Enterprise by 1.4% during the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company's stock worth $627,000 after buying an additional 22 shares during the last quarter. Finally, Menard Financial Group LLC grew its stake in shares of Axon Enterprise by 0.8% during the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company's stock worth $1,204,000 after buying an additional 24 shares during the last quarter. Institutional investors own 79.08% of the company's stock.

Remove Ads

Axon Enterprise Trading Up 0.5 %

NASDAQ AXON traded up $2.53 during mid-day trading on Tuesday, reaching $528.28. 950,728 shares of the stock were exchanged, compared to its average volume of 834,183. The stock has a market cap of $40.28 billion, a P/E ratio of 136.51, a P/E/G ratio of 5.17 and a beta of 1.12. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $715.99. The stock has a 50 day simple moving average of $607.58 and a 200-day simple moving average of $526.43.

Insiders Place Their Bets

In other Axon Enterprise news, President Joshua Isner sold 1,291 shares of the business's stock in a transaction that occurred on Tuesday, December 17th. The stock was sold at an average price of $642.43, for a total value of $829,377.13. Following the transaction, the president now directly owns 181,892 shares of the company's stock, valued at approximately $116,852,877.56. The trade was a 0.70 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now owns 6,929 shares in the company, valued at $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 6,407 shares of company stock worth $4,122,925. Company insiders own 6.10% of the company's stock.

Analysts Set New Price Targets

Several research firms recently weighed in on AXON. Needham & Company LLC reissued a "buy" rating and set a $600.00 price objective on shares of Axon Enterprise in a report on Wednesday, February 26th. The Goldman Sachs Group lifted their price target on Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a research note on Monday, January 27th. TD Cowen initiated coverage on Axon Enterprise in a report on Wednesday, January 8th. They set a "buy" rating and a $700.00 price target on the stock. Robert W. Baird raised their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an "outperform" rating in a report on Friday, December 6th. Finally, Morgan Stanley raised shares of Axon Enterprise from an "equal weight" rating to an "overweight" rating and boosted their target price for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. Three research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $587.38.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.